Novel RNAs Identified From an In-Depth Analysis of the Transcriptome of Human Chromosomes 21 and 22

Abstract

In this report, we have achieved a richer view of the transcriptome for Chromosomes 21 and 22 by using high-density oligonucleotide arrays on cytosolic poly(A)+ RNA. Conservatively, only 31.4% of the observed transcribed nucleotides correspond to well-annotated genes, whereas an additional 4.8% and 14.7% correspond to mRNAs and ESTs, respectively. Approximately 85% of the known exons were detected, and up to 21% of known genes have only a single isoform based on exon-skipping alternative expression. Overall, the expression of the well-characterized exons falls predominately into two categories, uniquely or ubiquitously expressed with an identifiable proportion of antisense transcripts. The remaining observed transcription (49.0%) was outside of any known annotation. These novel transcripts appear to be more cell-line-specific and have lower and less variation in expression than the well-characterized genes. Novel transcripts were further characterized based on their distance to annotations, transcript size, coding capacity, and identification as antisense to intronic sequences. By RT-PCR, 126 novel transcripts were independently verified, resulting in a 65% verification rate. These observations strongly support the argument for a re-evaluation of the total number of human genes and an alternative term for “gene” to encompass these growing, novel classes of RNA transcripts in the human genome.

Footnotes

  • [Supplemental material is available online at www.genome.org. All novel, sequence-verified transcripts (Supplemental Table S4) have been submitted to dbEST (CF798425–CF798506). The following individuals kindly provided unpublished information as indicated in the paper: K. Cole, V. Truong, D. Barone, G. McGall, H.H. Ng, E.A. Sekinger, A.J. Williams, R. Wheeler, B. Wong, and K. Struhl.]

  • Article and publication are at http://www.genome.org/cgi/doi/10.1101/gr.2094104.

  • 1 Corresponding author. E-MAIL dione_kampa{at}affymetrix.com; FAX (408) 481-0422.

    • Accepted January 6, 2004.
    • Received October 27, 2003.
| Table of Contents

Preprint Server